1-17 of 17
splenomegaly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN

Aaron T. Gerds
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 407–414.
https://doi.org/10.1182/hematology.2019000048
Published: 2019
Journal Articles

Common variable immune deficiency: case studies

Charlotte Cunningham-Rundles
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 449–456.
https://doi.org/10.1182/hematology.2019002062
Published: 2019
Journal Articles

Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyond

Claire N. Harrison, Donal P. McLornan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 489–497.
https://doi.org/10.1182/asheducation-2017.1.489
Published: 2017
Journal Articles

Management of symptoms in polycythemia vera and essential thrombocythemia patients

Deepti Radia, Holly L. Geyer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 340–348.
https://doi.org/10.1182/asheducation-2015.1.340
Published: 2015
Journal Articles

Evidence for Janus kinase (JAK) inhibitors for the prevention of major morbid events in patients with myeloproliferative neoplasms (MPNs)

Naveen Pemmaraju, Ruben Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 649–651.
https://doi.org/10.1182/asheducation-2015.1.649
Published: 2015
Journal Articles

Management of prolymphocytic leukemia

Claire Dearden
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 361–367.
https://doi.org/10.1182/asheducation-2015.1.361
Published: 2015
Journal Articles

Therapy for myeloproliferative neoplasms: when, which agent, and how?

Holly L. Geyer, Ruben A. Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 277–286.
https://doi.org/10.1182/asheducation-2014.1.277
Published: 2014
Journal Articles

Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

David T. Yeung, Michael J. Mauro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 240–243.
https://doi.org/10.1182/asheducation-2014.1.240
Published: 2014
Journal Articles

JAK inhibition in the myeloproliferative neoplasms: lessons learned from the bench and bedside

Jason Gotlib
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 529–537.
https://doi.org/10.1182/asheducation-2013.1.529
Published: 2013
Journal Articles

The many faces of common variable immunodeficiency

Charlotte Cunningham-Rundles
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 301–305.
https://doi.org/10.1182/asheducation.V2012.1.301.3798316
Published: 2012
Journal Articles

The many faces of marginal zone lymphoma

Pier Luigi Zinzani
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 426–432.
https://doi.org/10.1182/asheducation.V2012.1.426.3798535
Published: 2012
Journal Articles

Management of Myelofibrosis

Alessandro M. Vannucchi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 222–230.
https://doi.org/10.1182/asheducation-2011.1.222
Published: 2011
Journal Articles

Assessing New Therapies and Their Overall Impact in Myelofibrosis

Ruben A. Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 115–121.
https://doi.org/10.1182/asheducation-2010.1.115
Published: 2010
Journal Articles

Hemophagocytic lymphohistiocytosis (HLH) and related disorders

Alexandra H. Filipovich
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 127–131.
https://doi.org/10.1182/asheducation-2009.1.127
Published: 2009
Journal Articles

Therapeutic potential of JAK2 inhibitors

Srdan Verstovsek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 636–642.
https://doi.org/10.1182/asheducation-2009.1.636
Published: 2009
Journal Articles

Chronic Myeloproliferative Disorders

Jerry L. Spivak, Giovanni Barosi, Gianni Tognoni, Tiziano Barbui, Guido Finazzi, Roberto Marchioli, Monia Marchetti
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 200–224.
https://doi.org/10.1182/asheducation-2003.1.200
Published: 2003
Journal Articles

A Polycythemia Vera Update: Diagnosis, Pathobiology, and Treatment

Thomas C. Pearson, Maria Messinezy, Nigel Westwood, Anthony R. Green, Anthony J. Bench, Anthony R. Green, Brian J.P. Huntly, Elizabeth P. Nacheva, Tiziano Barbui, Guido Finazzi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 51–68.
https://doi.org/10.1182/asheducation.V2000.1.51.51
Published: 2000